細胞表面マーカーの世界市場調査レポート：産業分析、規模、シェア、成長、動向、2023年から2030年までの予測

細胞表面マーカー市場の世界需要は、調査期間2023～2030年のCAGR9.5%で、2022年の7億4,986万米ドルから2030年にはほぼ15億4,987万米ドルの市場規模に達すると推定されます。

細胞表面抗原または膜マーカーとしても知られる細胞表面マーカーは、細胞の外表面に存在するタンパク質または分子です。これらのマーカーは、細胞間の識別、情報伝達、相互作用など様々な目的を果たすだけでなく、診断や治療目的にも使用されます。これらのマーカーは免疫学において重要な役割を果たしており、異なる細胞タイプを区別するのに役立ち、免疫系が異物や病原体を認識し、反応することを可能にしています。これらのマーカーはまた、細胞の生理学的状態、発生段階、組織や臓器内での特定の機能についての洞察を提供することもできます。

市場力学：

進化する細胞生物学と免疫学研究では、細胞表面マーカーを同定・分析し、細胞の機能と相互作用に光を当てる正確なツールが求められています。細胞マーカーは免疫反応を理解し、標的を絞ったがん治療を開発するために不可欠であり、免疫細胞や疾患サブタイプを特徴付けるツールの需要を煽っています。細胞マーカーは疾患サブタイプの同定に役立ち、個々の患者プロファイルに基づいたオーダーメイド治療という個別化医療のニーズに合致しています。疾患関連マーカーの同定は、診断検査や標的治療の原動力となり、バイオテクノロジーや製薬セクターの関心を集めています。抗体技術、イメージング法、データ解析の改良により、細胞マーカーの検出と解析能力が向上しています。マーカーは幹細胞の同定や分化段階を誘導し、再生医療への応用に不可欠です。産学連携と資金投入は、このダイナミックな分野における研究とバイオテクノロジーのイノベーションを支えています。

調査レポートは、ポーターのファイブフォースモデル、市場魅力度分析、バリューチェーン分析をカバーしています。これらのツールは、業界の構造を明確に把握し、世界レベルでの競合の魅力を評価するのに役立ちます。さらに、これらのツールは、細胞表面マーカーの世界市場における各セグメントを包括的に評価することもできます。細胞表面マーカー産業の成長と動向は、この調査に全体的なアプローチを提供します。

地域分析：

このセクションでは、北米、欧州、アジア太平洋、ラテンアメリカ、中東＆アフリカにおける細胞表面マーカー市場の現在および将来の需要を強調する地域展望をカバーします。さらに、本レポートでは、すべての主要地域における個々のアプリケーションセグメントの需要、推定・予測に焦点を当てています。

カスタム要件がある場合は、お問い合わせください。当社の調査チームは、お客様のニーズに応じてカスタマイズしたレポートを提供することができます。

目次

第1章 序文

第2章 エグゼクティブサマリー

• 市場のハイライト
• 世界市場スナップショット

第3章 細胞表面マーカー- 産業分析

• イントロダクション：市場力学
• 市場促進要因
• 市場抑制要因
• 市場機会
• 業界動向
• ポーターのファイブフォース分析
• 市場魅力度分析

第4章 バリューチェーン分析

• バリューチェーン分析
• 原材料分析
  • 原材料リスト
  • 原材料メーカーリスト
  • 主要原材料の価格動向
• 潜在的バイヤーのリスト
• マーケティングチャネル
  • ダイレクトマーケティング
  • インダイレクトマーケティング
  • マーケティングチャネル発展動向

第5章 細胞表面マーカーの世界市場分析：製品別

• 製品別概要
• 実績データと予測データ
• 製品別分析
• 抗体
• PCRアレイ

第6章 細胞表面マーカーの世界市場分析：ソース別

• ソース別概要
• 実績データと予測データ
• ソース別分析
• マウス
• ラット

第7章 細胞表面マーカーの世界市場分析：細胞タイプ別

• 細胞タイプ別概要
• 実績データと予測データ
• 細胞タイプ別分析
• T細胞
• B細胞
• NK細胞

第8章 細胞表面マーカーの世界市場分析：用途別

• 概要：用途別
• 実績データと予測データ
• 分析：用途別
• 調査（幹細胞、免疫学）
• 臨床（腫瘍学、血液学）

第9章 細胞表面マーカーの世界市場分析：エンドユーザー別

• エンドユーザー別概要
• 実績データと予測データ
• エンドユーザー別分析
• 病院

第10章 細胞表面マーカーの世界市場分析：地域別

• 地域別展望
• イントロダクション
• 北米の売上分析
  • 概要、実績と予測
  • セグメント別
  • 国別
  • 米国
  • カナダ
  • メキシコ
• 欧州売上分析
  • 概要、実績と予測
  • セグメント別
  • 国別
  • 英国
  • フランス
  • ドイツ
  • イタリア
  • ロシア
  • その他欧州
• アジア太平洋地域売上分析
  • 概要、実績と予測
  • セグメント別
  • 国別
  • 中国
  • インド
  • 日本
  • 韓国
  • オーストラリア
  • 東南アジア
  • その他アジア太平洋地域
• ラテンアメリカ売上分析
  • 概要、実績と予測
  • セグメント別
  • 国別
  • ブラジル
  • アルゼンチン
  • ペルー
  • チリ
  • その他ラテンアメリカ
• 中東・アフリカ売上分析
  • 概要、実績と予測
  • セグメント別
  • 国別
  • サウジアラビア
  • アラブ首長国連邦
  • イスラエル
  • 南アフリカ
  • その他中東とアフリカ

第11章 細胞表面マーカー企業の競合情勢

• 細胞表面マーカー市場の競合
• 提携・協力・合意
• 合併・買収
• 新製品上市
• その他の開発

第12章 企業プロファイル

• 企業シェア分析
• 市場集中度
• Thermo Fisher Scientific（US）
• QIAGEN N.V.（Netherlands）
• Becton
• Dickinson and Company（US）
• F. Hoffman-La Roche（Switzerland）
• Bio-Rad Laboratories（US）
• Danaher Corporation（US）
• Abcam（UK）
• GenScript（China）
• BioLegend（US）
• Cell Signaling Technology（US）
• Marck KGaA（Germany）
• Bio-Techne（US）

注-企業プロファイルにおいて、財務の詳細や最近の動向は、入手可能な情報に基づいているか、非公開会社の場合はカバーしていない可能性があります。

LIST OF TABLES

• Market Snapshot
• Drivers : Impact Analysis
• Restraints : Impact Analysis
• List of Raw Material
• List of Raw Material Manufactures
• Analysis by Product (USD MN)
• Antibody Market Sales by Geography (USD MN)
• PCR Array Market Sales by Geography (USD MN)
• Analysis Market by Source (USD MN)
• Mice Market Sales by Geography (USD MN)
• Rat Market Sales by Geography (USD MN)
• Analysis by Cell Type (USD MN)
• T Cells Market Sales by Geography (USD MN)
• B Cells Market Sales by Geography (USD MN)
• NK Cell Market Sales by Geography (USD MN)
• Analysis by Application (USD MN)
• Research (Stem Cell, Immunology) Market Sales by Geography (USD MN)
• Clinical (Oncology, Hematology) Market Sales by Geography (USD MN)
• Analysis by End User (USD MN)
• Hospitals Market Sales by Geography (USD MN)
• Global Cell Surface Markers Market Sales by Geography (USD MN)
• North America Market Analysis (USD MN)
• United State Market Analysis (USD MN)
• Canada Market Analysis (USD MN)
• Mexico Market Analysis (USD MN)
• Europe Market Analysis (USD MN)
• Europe Market Estimate by Country (USD MN)
• United Kingdom Market Analysis (USD MN)
• France Market Analysis (USD MN)
• Germany Market Analysis (USD MN)
• Italy Market Analysis (USD MN)
• Russia Market Analysis (USD MN)
• Spain Market Analysis (USD MN)
• Rest of Europe Market Analysis (USD MN)
• Asia Pacific Market Analysis (USD MN)
• China Market Analysis (USD MN)
• Japan Market Analysis (USD MN)
• India Market Analysis (USD MN)
• South Korea Market Analysis (USD MN)
• Australia Market Analysis (USD MN)
• South East Asia Market Analysis (USD MN)
• Rest of Asia Pacific Market Analysis (USD MN)
• Latin America Market Analysis (USD MN)
• Brazil Market Analysis (USD MN)
• Argentina Market Analysis (USD MN)
• Peru Market Analysis (USD MN)
• Chile Market Analysis (USD MN)
• Rest of Latin America Market Analysis (USD MN)
• Middle East & Africa Market Analysis (USD MN)
• Saudi Arabia Market Analysis (USD MN)
• UAE Market Analysis (USD MN)
• Israel Market Analysis (USD MN)
• South Africa Market Analysis (USD MN)
• Rest of Middle East and Africa Market Analysis (USD MN)
• Partnership/Collaboration/Agreement
• Mergers And Acquisition

LIST OF FIGURES

• Research Scope of Cell Surface Markers Report
• Market Research Process
• Market Research Methodology
• Global Cell Surface Markers Market Size, by Region (USD MN)
• Porters Five Forces Analysis
• Market Attractiveness Analysis by Product
• Market Attractiveness Analysis by Source
• Market Attractiveness Analysis by Cell Type
• Market Attractiveness Analysis by Application
• Market Attractiveness Analysis by End User
• Market Attractiveness Analysis by Region
• Value Chain Analysis
• Global Market Analysis by Product (USD MN)
• Antibody Market Sales by Geography (USD MN)
• PCR Array Market Sales by Geography (USD MN)
• Global Market Analysis by Source (USD MN)
• Mice Market Sales by Geography (USD MN)
• Rat Market Sales by Geography (USD MN)
• Global Market Analysis by Cell Type (USD MN)
• T Cells Market Sales by Geography (USD MN)
• B Cells Market Sales by Geography (USD MN)
• NK Cell Market Sales by Geography (USD MN)
• Global Market Analysis by Application (USD MN)
• Research (Stem Cell, Immunology) Market Sales by Geography (USD MN)
• Clinical (Oncology, Hematology) Market Sales by Geography (USD MN)
• Global Market Analysis by End User (USD MN)
• Hospitals Market Sales by Geography (USD MN)
• Global Market Sales (USD MN)
• North America Market Sales (USD MN)
• Europe Market Sales (USD MN)
• Asia Pacific Market Sales (USD MN)
• Latin America Market Sales (USD MN)
• Middle East & Africa Market Sales (USD MN)
• Recent Development in Industry
• Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

The global demand for Cell Surface Markers Market is presumed to reach the market size of nearly USD 1549.87 MN by 2030 from USD 749.86 MN in 2022 with a CAGR of 9.5% under the study period 2023 - 2030.

Cell surface markers, also known as cell surface antigens or membrane markers, are proteins or molecules present on the outer surface of cells. These markers serve various purposes, including identification, communication, and interaction between cells, as well as being used for diagnostic and therapeutic purposes. These play a significant role in immunology, as they help distinguish different cell types and allow the immune system to recognize and respond to foreign substances or pathogens. These markers can also provide insights into the physiological state of cells, their developmental stage, and their specific functions within tissues and organs.

MARKET DYNAMICS:

Evolving cell biology and immunology research demand accurate tools to identify and analyze cell surface markers, shedding light on cell functions and interactions. Cell markers are critical for understanding immune responses and developing targeted cancer therapies, fueling demand for tools to characterize immune cells and disease subtypes. Cell markers aid disease subtype identification, aligning with personalized medicine's need for tailored treatments based on individual patient profiles. Identification of disease-associated markers drives diagnostic tests and targeted therapies, attracting interest from the biotech and pharmaceutical sectors. Improved antibody tech, imaging methods, and data analysis enhance cell marker detection and analysis capabilities. Markers guide stem cell identification and differentiation stages, which are vital for regenerative medicine applications. Industry-academia collaboration and funding injections support research and biotechnology innovations in this dynamic field.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of cell surface markers. The growth and trends of cell surface markers industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the cell surface markers market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

• Antibody
• PCR Array

By Source

• Mice
• Rat

By Cell Type

• T Cells
• B Cells
• NK Cell

By Application

• Research (Stem Cell, Immunology)
• Clinical (Oncology, Hematology)

By End User

• Hospitals

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Cell Surface Markers market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Cell Surface Markers market include Thermo Fisher Scientific (US), QIAGEN N.V. (Netherlands), Becton, Dickinson and Company (US), F. Hoffman-La Roche (Switzerland), Bio-Rad Laboratories (US), Danaher Corporation (US), Abcam (UK), GenScript (China), BioLegend (US), Cell Signaling Technology (US), Marck KGaA (Germany), Bio-Techne (US). This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

• 1.1. Report Description
  • 1.1.1. Objective
  • 1.1.2. Target Audience
  • 1.1.3. Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1. Market Research Process
  • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3 . CELL SURFACE MARKERS - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Product
  • 3.7.2 Market Attractiveness Analysis By Source
  • 3.7.3 Market Attractiveness Analysis By Cell Type
  • 3.7.4 Market Attractiveness Analysis By Application
  • 3.7.5 Market Attractiveness Analysis By End User
  • 3.7.6 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1. List of Raw Materials
  • 4.2.2. Raw Material Manufactures List
  • 4.2.3. Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1. Direct Marketing
  • 4.4.2. Indirect Marketing
  • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL CELL SURFACE MARKERS MARKET ANALYSIS BY PRODUCT

• 5.1 Overview by Product
• 5.2 Historical and Forecast Data
• 5.3 Analysis by Product
• 5.4 Antibody Historic and Forecast Sales by Regions
• 5.5 PCR Array Historic and Forecast Sales by Regions

6 . GLOBAL CELL SURFACE MARKERS MARKET ANALYSIS BY SOURCE

• 6.1 Overview by Source
• 6.2 Historical and Forecast Data
• 6.3 Analysis by Source
• 6.4 Mice Historic and Forecast Sales by Regions
• 6.5 Rat Historic and Forecast Sales by Regions

7 . GLOBAL CELL SURFACE MARKERS MARKET ANALYSIS BY CELL TYPE

• 7.1 Overview by Cell Type
• 7.2 Historical and Forecast Data
• 7.3 Analysis by Cell Type
• 7.4 T Cells Historic and Forecast Sales by Regions
• 7.5 B Cells Historic and Forecast Sales by Regions
• 7.6 NK Cell Historic and Forecast Sales by Regions

8 . GLOBAL CELL SURFACE MARKERS MARKET ANALYSIS BY APPLICATION

• 8.1 Overview by Application
• 8.2 Historical and Forecast Data
• 8.3 Analysis by Application
• 8.4 Research (Stem Cell, Immunology) Historic and Forecast Sales by Regions
• 8.5 Clinical (Oncology, Hematology) Historic and Forecast Sales by Regions

9 . GLOBAL CELL SURFACE MARKERS MARKET ANALYSIS BY END USER

• 9.1 Overview by End User
• 9.2 Historical and Forecast Data
• 9.3 Analysis by End User
• 9.4 Hospitals Historic and Forecast Sales by Regions

10 . GLOBAL CELL SURFACE MARKERS MARKET ANALYSIS BY GEOGRAPHY

• 10.1. Regional Outlook
• 10.2. Introduction
• 10.3. North America Sales Analysis
  • 10.3.1. Overview, Historic and Forecast Data Sales Analysis
  • 10.3.2. North America By Segment Sales Analysis
  • 10.3.3. North America By Country Sales Analysis
  • 10.3.4. United State Sales Analysis
  • 10.3.5. Canada Sales Analysis
  • 10.3.6. Mexico Sales Analysis
• 10.4. Europe Sales Analysis
  • 10.4.1. Overview, Historic and Forecast Data Sales Analysis
  • 10.4.2. Europe by Segment Sales Analysis
  • 10.4.3. Europe by Country Sales Analysis
  • 10.4.4. United Kingdom Sales Analysis
  • 10.4.5. France Sales Analysis
  • 10.4.6. Germany Sales Analysis
  • 10.4.7. Italy Sales Analysis
  • 10.4.8. Russia Sales Analysis
  • 10.4.9. Rest Of Europe Sales Analysis
• 10.5. Asia Pacific Sales Analysis
  • 10.5.1. Overview, Historic and Forecast Data Sales Analysis
  • 10.5.2. Asia Pacific by Segment Sales Analysis
  • 10.5.3. Asia Pacific by Country Sales Analysis
  • 10.5.4. China Sales Analysis
  • 10.5.5. India Sales Analysis
  • 10.5.6. Japan Sales Analysis
  • 10.5.7. South Korea Sales Analysis
  • 10.5.8. Australia Sales Analysis
  • 10.5.9. South East Asia Sales Analysis
  • 10.5.10. Rest Of Asia Pacific Sales Analysis
• 10.6. Latin America Sales Analysis
  • 10.6.1. Overview, Historic and Forecast Data Sales Analysis
  • 10.6.2. Latin America by Segment Sales Analysis
  • 10.6.3. Latin America by Country Sales Analysis
  • 10.6.4. Brazil Sales Analysis
  • 10.6.5. Argentina Sales Analysis
  • 10.6.6. Peru Sales Analysis
  • 10.6.7. Chile Sales Analysis
  • 10.6.8. Rest of Latin America Sales Analysis
• 10.7. Middle East & Africa Sales Analysis
  • 10.7.1. Overview, Historic and Forecast Data Sales Analysis
  • 10.7.2. Middle East & Africa by Segment Sales Analysis
  • 10.7.3. Middle East & Africa by Country Sales Analysis
  • 10.7.4. Saudi Arabia Sales Analysis
  • 10.7.5. UAE Sales Analysis
  • 10.7.6. Israel Sales Analysis
  • 10.7.7. South Africa Sales Analysis
  • 10.7.8. Rest Of Middle East And Africa Sales Analysis

11 . COMPETITIVE LANDSCAPE OF THE CELL SURFACE MARKERS COMPANIES

• 11.1. Cell Surface Markers Market Competition
• 11.2. Partnership/Collaboration/Agreement
• 11.3. Merger And Acquisitions
• 11.4. New Product Launch
• 11.5. Other Developments

12 . COMPANY PROFILES OF CELL SURFACE MARKERS INDUSTRY

• 12.1. Company Share Analysis
• 12.2. Market Concentration Rate
• 12.3. Thermo Fisher Scientific (US)
  • 12.3.1. Company Overview
  • 12.3.2. Company Revenue
  • 12.3.3. Products
  • 12.3.4. Recent Developments
• 12.4. QIAGEN N.V. (Netherlands)
  • 12.4.1. Company Overview
  • 12.4.2. Company Revenue
  • 12.4.3. Products
  • 12.4.4. Recent Developments
• 12.5. Becton
  • 12.5.1. Company Overview
  • 12.5.2. Company Revenue
  • 12.5.3. Products
  • 12.5.4. Recent Developments
• 12.6. Dickinson and Company (US)
  • 12.6.1. Company Overview
  • 12.6.2. Company Revenue
  • 12.6.3. Products
  • 12.6.4. Recent Developments
• 12.7. F. Hoffman-La Roche (Switzerland)
  • 12.7.1. Company Overview
  • 12.7.2. Company Revenue
  • 12.7.3. Products
  • 12.7.4. Recent Developments
• 12.8. Bio-Rad Laboratories (US)
  • 12.8.1. Company Overview
  • 12.8.2. Company Revenue
  • 12.8.3. Products
  • 12.8.4. Recent Developments
• 12.9. Danaher Corporation (US)
  • 12.9.1. Company Overview
  • 12.9.2. Company Revenue
  • 12.9.3. Products
  • 12.9.4. Recent Developments
• 12.10. Abcam (UK)
  • 12.10.1. Company Overview
  • 12.10.2. Company Revenue
  • 12.10.3. Products
  • 12.10.4. Recent Developments
• 12.11. GenScript (China)
  • 12.11.1. Company Overview
  • 12.11.2. Company Revenue
  • 12.11.3. Products
  • 12.11.4. Recent Developments
• 12.12. BioLegend (US)
  • 12.12.1. Company Overview
  • 12.12.2. Company Revenue
  • 12.12.3. Products
  • 12.12.4. Recent Developments
• 12.13. Cell Signaling Technology (US)
  • 12.13.1. Company Overview
  • 12.13.2. Company Revenue
  • 12.13.3. Products
  • 12.13.4. Recent Developments
• 12.14. Marck KGaA (Germany)
  • 12.14.1. Company Overview
  • 12.14.2. Company Revenue
  • 12.14.3. Products
  • 12.14.4. Recent Developments
• 12.15. Bio-Techne (US)
  • 12.15.1. Company Overview
  • 12.15.2. Company Revenue
  • 12.15.3. Products
  • 12.15.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies